Shares were up after the company announced higher-than-expected second quarter earnings last week. Mr. Ellis also said the market for spinal implants and cardiac rhythm management devices might be stabilizing.
Related Articles on Supply Chain:
Commentary: Pharmaceutical Companies More Careful About Off-Label Promotion
GE Unveils Discovery IGS 730 Interventional Imaging System at RSNA
Medtronic Sales High Despite Challenges for Heart and Spine Implants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
